Immediate Impact
1 from Science/Nature 56 standout
Citing Papers
Healthy Lifestyle and Cancer Risk: Modifiable Risk Factors to Prevent Cancer
2024 Standout
The promise and challenges of combination therapies with antibody-drug conjugates in solid tumors
2024 Standout
Works of Heather Beckwith being referenced
SGNLVA-001: A phase I open-label dose escalation and expansion study of SGN-LIV1A administered weekly in breast cancer.
2020
Tumor grade and progesterone receptor status predict 21-gene recurrence score in early stage invasive breast carcinoma
2018
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Heather Beckwith | 177 | 149 | 40 | 92 | 22 | 357 | |
| Hee-Chul Shin | 154 | 150 | 31 | 99 | 33 | 392 | |
| Elisabeth C. Inwald | 154 | 73 | 23 | 59 | 31 | 404 | |
| Danielle Crawley | 110 | 114 | 15 | 136 | 33 | 370 | |
| Andreas Nearchou | 200 | 103 | 45 | 38 | 14 | 369 | |
| Séverine Sarp | 191 | 105 | 34 | 115 | 18 | 387 | |
| Lucia Vassalli | 218 | 60 | 25 | 50 | 30 | 408 | |
| Kirsti Vik Hjerkind | 189 | 102 | 22 | 31 | 15 | 321 | |
| Lynn M. Neilson | 194 | 65 | 13 | 173 | 25 | 382 | |
| JN Ingle | 267 | 136 | 15 | 61 | 27 | 408 | |
| Kairui Jin | 91 | 119 | 37 | 60 | 21 | 375 |
All Works
Login with ORCID to disown or claim papers
Loading papers...